Skip to main content
. 2022 Feb 21;18(5):1878–1895. doi: 10.7150/ijbs.69934

Table 2.

Difference of HSPA5 level between benign and malignant nasopharyngeal masses (N=61, X2 Test)

N Scores of immunohistochemical staining X 2 p
Weak positive/Negative (0-2) Positive (3-4) Strong positive (5-6)
Benign nasopharyngeal mass 21 19 2 0 24.16 <0.0001
NPC 40 10 15 15
Radiosensitive NPC 20 8 8 4 6.933 0.0312
Radioresistant NPC 20 2 7 11

Using X2 test. NPC, Nasopharyngeal Carcinoma.